Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
OSAIC HOLDINGS, INC. GDO Western Asset Global Corporate Opportunity Fund Inc. 13G/A 4.7% 6mo
OSAIC HOLDINGS, INC. RSF RiverNorth Capital & Income Fund, Inc. 13G/A 9.4% 6mo
Rosalind Advisors, Inc. TLPH Talphera, Inc. 13G/A 9.9% 6mo
Egor Romanyuk MCRP Micropolis AI Robotics 13G 15.45% 6mo
Walden Jon Matthew HUBC Hub Cyber Security Ltd. 13G 8.4% 6mo
Ephraim G Fields DLPN Dolphin Entertainment, Inc. 13G 5.9% 6mo
John C. Malone LILA Liberty Latin America Ltd. 13D/A 8.8% 6mo
Streeterville Management LLC AEHL Antelope Enterprise Holdings Ltd 13G/A 0% 6mo
Feis Equities LLC ARCL ARC Group Acquisition I Corp. 13G/A 4.97% 6mo
HESTIA CAPITAL PARTNERS LP PBI Pitney Bowes Inc 13D/A 4.2% 6mo
Onex Corporation EEX Emerald Holding, Inc. 13D/A 93% 6mo
Famatown Finance Ltd. INSW International Seaways, Inc. 13D/A 14.65% 6mo
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 20.3% 6mo
SCULLY WILLIAM P PRTA Prothena Corp Public Ltd Co 13G/A 10.3% 6mo
Hilary L Shane Revocable Trust FONR Fonar Corp 13G/A 11.6% 6mo
Saba Capital Management, L.P. GLO Clough Global Opportunities Fund 13D/A 8.18% 6mo
Matrix Capital Management Company, LP AURA Aura Biosciences, Inc. 13D/A 0% 6mo
Access Industries Management, LLC DOCN DigitalOcean Holdings, Inc. 13D/A 21.04% 6mo
Brian Miller SKIN SkinHealth Systems Inc. 13D/A 25.74% 6mo
Lynrock Lake LP RDCM Radcom Ltd 13D/A 15.7% 6mo
Sofinnova Crossover I SLP ABVX Abivax S.A. 13D/A 6.7% 6mo
ADW Capital Partners, L.P. CODI Compass Diversified Holdings 13D/A 17.9% 6mo
SIT INVESTMENT ASSOCIATES INC MIN Aberdeen Intermediate Income Fund 13D/A 28.8% 6mo
BAKER BROS. ADVISORS LP INCY Incyte Corp 13D/A 15.4% 6mo
Alexandra Seros EVC Entravision Communications Corp 13D/A 13.61% 6mo
SC US (TTGP), LTD. CART Maplebear Inc. 13D/A 11.9% 6mo
Liberty Mutual Foundation Inc. CRGY Crescent Energy Co 13D/A 1.3% 6mo
CMLS Holdings LLC WGS GeneDx Holdings Corp. 13D/A 1.8% 6mo
Panacea Venture Healthcare Fund II, L.P. ATRA Atara Biotherapeutics, Inc. 13D/A 16.1% 6mo
HAMPTON FINANCIAL CORP. ICON Icon Energy Corp 13G 10.1% 6mo
GOLDMAN SACHS GROUP INC SPTX Seaport Therapeutics, Inc. 13G 5.5% 6mo
Bin Zhai CNF CNFinance Holdings Ltd. 13D 66.95% 6mo
JANE STREET GROUP, LLC RIOT Riot Platforms, Inc. 13G 5.3% 6mo
AI DEN-MAB LLC COAG Hemab Therapeutics Holdings, Inc. 13D 10.4% 6mo
Stonepine Capital Management, LLC CLRB Cellectar Biosciences, Inc. 13G 9.9% 6mo
RA CAPITAL MANAGEMENT, L.P. COAG Hemab Therapeutics Holdings, Inc. 13G 16.6% 6mo
Paradigm Biocapital Advisors LP ASMB Assembly Biosciences, Inc. 13G 5.4% 6mo
GENERAL ATLANTIC, L.P. SPTX Seaport Therapeutics, Inc. 13D 11.5% 6mo
GLAZER CAPITAL, LLC TPH Tri Pointe Homes, Inc. 13G 5.4% 6mo
Advisors Asset Management, Inc. IGA Voya Global Advantage & Premium Opportunity Fund 13G/A 4.61% 6mo
Ramaswamy Vivek ASST Strive, Inc. 13D/A 8.4% 6mo
GOLDMAN SACHS GROUP INC CCIX Churchill Capital Corp IX 13G/A 2.9% 6mo
Western Standard LLC OSG Octave Specialty Group Inc 13G/A 4.99% 6mo
MORGAN STANLEY CBZ CBIZ, Inc. 13G/A 3% 6mo
GOLDMAN SACHS GROUP INC OACC Oaktree Acquisition Corp. III Life Sciences 13G 6.2% 6mo
JANE STREET GROUP, LLC OSG Octave Specialty Group Inc 13G/A 1.7% 6mo
NORGES BANK CE Celanese Corp 13G 6.19% 6mo
Poplar Point Capital Management LLC RSKIA George Risk Industries, Inc. 13G 5.16% 6mo
Opaleye Management Inc. RZLT Rezolute, Inc. 13G/A 6.58% 6mo
MORGAN STANLEY CNM Core & Main, Inc. 13G/A 2.7% 6mo